CCM
PFE icon

Cortex Capital Management’s Pfizer PFE Stock Holding History

Cortex Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-189,720
Closed -$5.34M – 40
2014
Q2 		$5.34M Buy
189,720
+84,320
+80% +$2.4M 3.87% 8
2014
Q1 		$3.21M Sell
105,400
-21,080
-17% -$629K 2.76% 13
2013
Q4 		$3.68M Buy
+126,480
New +$3.68M 2.25% 14

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cortex Capital Management's PFE Position: Q3 2014 in Review

Cortex Capital Management sold out of Pfizer (PFE) in Q3 2014, closing a stake of 189,720 shares — an estimated $5.34M sold.

Cortex Capital Management first reported a position in PFE in Q4 2013 and held it in 3 quarters. The position peaked at $5.34M in Q2 2014. 1,742 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • Cortex Capital Management reported no remaining Pfizer position as of Q3 2014 after selling out during the quarter.
  • Cortex Capital Management sold 189,720 Pfizer shares in Q3 2014, an estimated $5.34M.
  • Cortex Capital Management first reported a position in Pfizer in Q4 2013 and held it in 3 quarters.
  • Cortex Capital Management's Pfizer position peaked at $5.34M in Q2 2014.
  • 1,742 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Cortex Capital Management's 13F filing for Q3 2014, filed 13 Nov 2014.